AJP - Heart and Circulatory Physiology, Vol 271, Issue 3 906-H913, Copyright © 1996 by American Physiological Society

ARTICLES

Captopril prevents vascular and fibrotic changes but not cardiac hypertrophy in aortic-banded rats

C. P. Regan, P. G. Anderson, S. P. Bishop and K. H. Berecek
Department of Physiology and Biophysics, University of Alabama at Birmingham 35294, USA.

To determine the role of the renin-angiotensin system (RAS) on cardiovascular remodeling in a pressure overload model of cardiac hypertrophy, a subdiaphragmatic aortic band was placed in adult male, Sprague-Dawley rats. Rats were left untreated (AB) or given captopril (Cap, 400 mg/l) (AB-Cap). Sham-operated controls were either left untreated (S) or given Cap (S-Cap). After 4 wk, rats were catheterized, and carotid and femoral mean arterial pressures (CMAP and FMAP in mmHg, respectively) were recorded. Hearts were isolated, and minimal coronary resistance (MCR) was determined. Hearts were then perfusion fixed, total and regional heart weights were recorded, and sections were processed for vessel morphology. Changes in coronary artery medical thickness and perivascular fibrosis were assessed by quantitative image analysis. CMAP was significantly higher in AB and AB-Cap than S or S-Cap rats (P < 0.05). There was no difference in FMAP in AB vs. S rats, but AB-Cap and S-Cap had lower FMAP values than S rats. Total heart weight and left ventricular weight-to-body weight ratios were increased in AB and AB-Cap rats compared with S and S-Cap rats (P < 0.05). MCR of AB was greater than S and S-Cap rats. MCR of AB-Cap rats was significantly greater than S and S-Cap rats but was significantly less than AB rats. In coronary vessels, medial thickness was greatest in AB, whereas there was no difference among AB-Cap, S, and S-Cap rats. Similarly, the increase in perivascular fibrosis was greatest in AB rats, and there was no difference among AB-Cap, S, and S-Cap rats. These data suggest that the RAS, independent of increased arterial pressure, is critical for the development of the vascular and fibrotic changes that occur in this model of pressure overload hypertrophy.

This article has been cited by other articles:

				P. A. Modesti, S. Vanni, I. Bertolozzi, I. Cecioni, G. Polidori, R. Paniccia, B. Bandinelli, A. Perna, P. Liguori, M. Boddi, et al. Early sequence of cardiac adaptations and growth factor formation in pressure- and volume-overload hypertrophy Am J Physiol Heart Circ Physiol, September 1, 2000; 279(3): H976 - H985. [Abstract] [Full Text] [PDF]

				L. J. Heller, J. A. Opsahl, S. E. Wernsing, R. Saxena, and S. A. Katz Myocardial and plasma renin-angiotensinogen dynamics during pressure-induced cardiac hypertrophy Am J Physiol Regulatory Integrative Comp Physiol, March 1, 1998; 274(3): R849 - R856. [Abstract] [Full Text] [PDF]

				K. T. Weber Extracellular Matrix Remodeling in Heart Failure : A Role for De Novo Angiotensin II Generation Circulation, December 2, 1997; 96(11): 4065 - 4082. [Full Text]

				E. Balcells, Q. C. Meng, W. H. Johnson Jr., S. Oparil, and L. J. Dell'Italia Angiotensin II formation from ACE and chymase in human and animal hearts: methods and species considerations Am J Physiol Heart Circ Physiol, October 1, 1997; 273(4): H1769 - H1774. [Abstract] [Full Text] [PDF]